Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeStance Health (LFST) Revenue (2020 - 2025)

LifeStance Health (LFST) has disclosed Revenue for 6 consecutive years, with $382.2 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 17.43% to $382.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 13.85% year-over-year, with the annual reading at $1.4 billion for FY2025, 13.85% up from the prior year.
  • Revenue for Q4 2025 was $382.2 million at LifeStance Health, up from $363.8 million in the prior quarter.
  • The five-year high for Revenue was $382.2 million in Q4 2025, with the low at $143.1 million in Q1 2021.
  • Average Revenue over 5 years is $262.9 million, with a median of $261.2 million recorded in 2023.
  • The sharpest move saw Revenue surged 253.22% in 2021, then grew 10.56% in 2025.
  • Over 5 years, Revenue stood at $190.0 million in 2021, then increased by 20.72% to $229.4 million in 2022, then increased by 22.34% to $280.6 million in 2023, then increased by 15.99% to $325.5 million in 2024, then increased by 17.43% to $382.2 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $382.2 million, $363.8 million, and $345.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.